APO-DEXLANSOPRAZOLE

Identification of Apo-Dexlansoprazole

No description

Google image searchProduct monograph

Active ingredient

dexlansoprazole, 30 MG

DIN: 02528991

Dosage form(s): CAPSULE (DELAYED RELEASE)

Route(s) of administration: NASOGASTRIC, ORAL

Schedule: Prescription

Company: APOTEX INC

Date: 26-FEB-2024

ATC:

• A02 — DRUGS FOR ACID RELATED DISORDERS (ATC, ATC/DDD, )
• A02B — DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) (ATC, ATC/DDD)
• A02BC — Proton pump inhibitors (ATC, ATC/DDD)
• A02BC06 — DEXLANSOPRAZOLE (ATC/DDD)

Reference brand drug: Dexilant

External Links for Apo-Dexlansoprazole

Search on Google

• Apo-Dexlansoprazole side effects
• Apo-Dexlansoprazole dosage
• dexlansoprazole side effects
• dexlansoprazole dosage

Apotex Inc

Go to Apotex website to see drug product details. Sometimes you can find apo-dexlansoprazole photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.